Competitors of Gujarat Themis Biosyn Ltd in the Pharmaceuticals Sector
| Stock Name | Market Cap | Current Price | High / Low | Stock P/E | Book Value | Dividend Yield | ROCE | ROE | Face Value |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Themis Biosyn Ltd | 3,748 Cr. | 344 | 390/108 | 68.5 | 18.5 | 0.19 % | 45.0 % | 33.8 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 51.6 Cr. | 69.5 | 78.7/19.6 | 35.3 | 9.58 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 27.2 Cr. | 18.6 | 18.8/7.60 | 160 | 5.00 | 0.00 % | 4.06 % | 3.33 % | 10.0 |
| Godavari Drugs Ltd | 98.0 Cr. | 130 | 155/82.1 | 15.2 | 51.8 | 0.00 % | 12.7 % | 15.5 % | 10.0 |
| Glenmark Life Sciences Ltd | 14,548 Cr. | 1,189 | 1,335/609 | 32.6 | 190 | 1.89 % | 28.1 % | 21.1 % | 2.00 |
| Gennex Laboratories Ltd | 602 Cr. | 26.5 | 29.0/7.51 | 40.2 | 7.24 | 0.00 % | 14.4 % | 10.4 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 9.47 Cr. | 19.6 | 28.5/10.0 | 189 | 13.3 | 0.00 % | 3.19 % | 0.84 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 366 Cr. | 778 | 1,054/650 | 21.1 | 258 | 0.09 % | 17.5 % | 14.9 % | 10.0 |
| Fervent Synergies Ltd | 57.1 Cr. | 19.0 | 27.8/14.6 | 10.1 | 0.00 % | 34.8 % | 34.9 % | 10.0 | |
| Fermenta Biotech Ltd | 834 Cr. | 283 | 332/144 | 98.2 | 0.44 % | 3.20 % | 5.59 % | 5.00 | |
| Fabino Enterprises Ltd | 5.88 Cr. | 28.0 | 43.8/23.6 | 118 | 19.8 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
| Evoq Remedies Ltd | 22.0 Cr. | 8.85 | 19.4/8.50 | 49.0 | 18.6 | 0.00 % | 1.91 % | 1.80 % | 10.0 |
| Everest Organics Ltd | 109 Cr. | 136 | 184/110 | 49.7 | 0.00 % | 6.03 % | 0.30 % | 10.0 | |
| Murae Organisor Ltd | 32.6 Cr. | 1.32 | 3.10/0.90 | 2.26 | 0.00 % | 0.79 % | 0.13 % | 2.00 | |
| Dipna Pharmachem Ltd | 19.5 Cr. | 8.10 | 17.9/7.00 | 17.9 | 15.6 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
| Decipher Labs Ltd | 17.2 Cr. | 17.0 | 25.8/14.4 | 78.1 | 21.6 | 0.00 % | 4.30 % | 7.46 % | 10.0 |
| Coral Laboratories Ltd | 320 Cr. | 895 | 999/262 | 14.0 | 497 | 0.22 % | 12.6 % | 9.58 % | 10.0 |
| Concord Drugs Ltd | 35.7 Cr. | 35.7 | 61.5/30.1 | 33.8 | 0.00 % | 4.50 % | 1.29 % | 10.0 | |
| Colinz Laboratories Ltd | 28.1 Cr. | 61.4 | 84.4/35.2 | 55.0 | 19.6 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
| Cian Healthcare Ltd | 14.2 Cr. | 5.66 | 26.5/5.66 | 56.6 | 23.1 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 9.79 Cr. | 65.2 | 87.0/28.0 | 9.07 | 85.3 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
| Checkpoint Trends Ltd | 5.22 Cr. | 9.55 | 12.4/4.09 | 47.5 | 0.97 | 0.00 % | 3.39 % | 5.83 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 52.2 Cr. | 69.2 | 160/63.0 | 34.1 | 38.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
| Brawn Biotech Ltd | 6.61 Cr. | 22.0 | 27.8/14.6 | 16.9 | 0.00 % | 25.9 % | 21.8 % | 10.0 | |
| Bharat Immunological & Biological Corporation Ltd | 122 Cr. | 28.1 | 43.9/22.5 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| Beryl Drugs Ltd | 18.1 Cr. | 35.7 | 45.0/19.4 | 30.1 | 17.6 | 0.00 % | 11.0 % | 9.07 % | 10.0 |
| BDH Industries Ltd | 206 Cr. | 358 | 408/162 | 21.0 | 108 | 1.26 % | 20.6 % | 16.9 % | 10.0 |
| Bacil Pharma Ltd | 14.8 Cr. | 25.1 | 29.2/4.68 | 2.07 | 0.00 % | 13.1 % | 13.8 % | 10.0 | |
| Aurobindo Pharma Ltd | 89,561 Cr. | 1,528 | 1,593/835 | 25.0 | 509 | 0.29 % | 14.1 % | 11.5 % | 1.00 |
| Auro Laboratories Ltd | 120 Cr. | 193 | 307/105 | 15.5 | 67.3 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
| Anuh Pharma Ltd | 1,013 Cr. | 202 | 265/124 | 17.5 | 58.1 | 1.24 % | 25.6 % | 19.5 % | 5.00 |
| ANG Lifesciences India Ltd | 68.3 Cr. | 52.3 | 86.1/44.5 | 59.0 | 0.00 % | 1.78 % | 8.72 % | 10.0 | |
| Ami Organics Ltd | 6,297 Cr. | 1,537 | 1,595/1,004 | 98.8 | 183 | 0.20 % | 16.0 % | 9.37 % | 10.0 |
| Amerise Biosciences Ltd | 5.29 Cr. | 0.80 | 0.93/0.54 | 0.81 | 0.00 % | 2.73 % | 2.75 % | 1.00 | |
| Ambalal Sarabhai Enterprises Ltd | 461 Cr. | 60.1 | 77.7/34.0 | 39.1 | 17.9 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
| Adline Chem Lab Ltd | 11.7 Cr. | 20.0 | 29.0/11.9 | 2.92 | 0.00 % | % | % | 10.0 | |
| Achyut Healthcare Ltd | 85.8 Cr. | 51.0 | 60.8/40.2 | 151 | 18.3 | 0.00 % | 3.27 % | 2.52 % | 10.0 |
| Abbott India Ltd | 59,413 Cr. | 27,972 | 30,521/21,907 | 48.0 | 1,741 | 1.47 % | 46.0 % | 34.9 % | 10.0 |
| Aarti Pharmalabs Ltd | 5,935 Cr. | 654 | 722/371 | 26.4 | 194 | 0.46 % | 16.6 % | 13.1 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 168 Cr. | 66.4 | 75.8/37.0 | 25.7 | 51.3 | 0.00 % | 6.18 % | 3.81 % | 10.0 |
| Zota Health Care Ltd | 1,659 Cr. | 625 | 725/372 | 34.8 | 0.16 % | 7.32 % | 16.8 % | 10.0 | |
| Wockhardt Ltd | 15,447 Cr. | 1,006 | 1,099/213 | 219 | 0.00 % | 0.83 % | 12.1 % | 5.00 | |
| Wanbury Ltd | 876 Cr. | 266 | 271/60.0 | 32.5 | 8.54 | 0.00 % | 58.1 % | % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | 21.3 | 0.00 % | 51.5 % | 163 % | 2.00 | |
| Venus Remedies Ltd | 459 Cr. | 344 | 430/225 | 16.1 | 365 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
| Unichem Laboratories Ltd | 4,507 Cr. | 641 | 695/399 | 336 | 0.00 % | 0.39 % | 1.17 % | 2.00 | |
| TTK Healthcare Ltd | 2,362 Cr. | 1,681 | 1,923/1,101 | 37.2 | 708 | 0.59 % | 8.67 % | 6.43 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,13,413 Cr. | 3,352 | 3,574/1,821 | 67.8 | 203 | 0.84 % | 23.2 % | 24.2 % | 5.00 |
| Themis Medicare Ltd | 2,381 Cr. | 258 | 288/142 | 47.6 | 41.0 | 0.19 % | 13.5 % | 11.8 % | 1.00 |
| Syncom Formulations (India) Ltd | 2,093 Cr. | 22.3 | 27.9/7.25 | 77.4 | 3.05 | 0.00 % | 10.4 % | 8.72 % | 1.00 |
| Suven Pharmaceuticals Ltd | 30,022 Cr. | 1,180 | 1,257/518 | 125 | 80.6 | 0.08 % | 18.8 % | 14.1 % | 1.00 |
| Suven Life Sciences Ltd | 3,203 Cr. | 147 | 169/60.8 | 12.4 | 0.00 % | 36.4 % | 36.3 % | 1.00 | |
| Sun Pharmaceuticals Industries Ltd | 4,43,739 Cr. | 1,846 | 1,874/1,068 | 42.1 | 265 | 0.73 % | 17.3 % | 16.7 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,666 Cr. | 736 | 820/264 | 195 | 0.00 % | 8.67 % | 33.5 % | 10.0 | |
| SMS Pharmaceuticals Ltd | 3,021 Cr. | 357 | 392/112 | 53.5 | 67.4 | 0.11 % | 11.2 % | 9.28 % | 1.00 |
| SMS Lifesciences India Ltd | 451 Cr. | 1,489 | 1,750/464 | 27.2 | 585 | 0.10 % | 6.86 % | 3.66 % | 10.0 |
| Shilpa Medicare Ltd | 8,268 Cr. | 848 | 960/296 | 201 | 208 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
| Sequent Scientific Ltd | 4,303 Cr. | 173 | 185/87.0 | 201 | 26.3 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
| Sanofi India Ltd | 16,539 Cr. | 7,178 | 7,600/4,253 | 33.6 | 298 | 2.33 % | 71.1 % | 51.5 % | 10.0 |
| RPG Life Sciences Ltd | 3,494 Cr. | 2,112 | 2,440/1,210 | 37.8 | 227 | 0.76 % | 34.6 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 8,460 Cr. | 5,101 | 5,643/4,637 | 39.3 | 324 | 0.98 % | 44.9 % | 33.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 139 Cr. | 39.6 | 79.2/35.4 | 20.4 | 0.00 % | 27.6 % | 16.8 % | 10.0 | |
| Pfizer Ltd | 25,940 Cr. | 5,667 | 6,453/3,802 | 43.0 | 786 | 0.62 % | 22.0 % | 16.1 % | 10.0 |
| Par Drugs & Chemicals Ltd | 288 Cr. | 234 | 325/183 | 19.8 | 69.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
| Panacea Biotec Ltd | 2,028 Cr. | 331 | 367/112 | 137 | 0.00 % | 3.60 % | 4.10 % | 1.00 | |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Orchid Pharma Ltd | 6,895 Cr. | 1,362 | 1,592/432 | 61.8 | 231 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
| Neuland Laboratories Ltd | 16,118 Cr. | 12,564 | 13,490/3,522 | 50.3 | 1,000 | 0.11 % | 33.3 % | 26.4 % | 10.0 |
| Nectar Lifescience Ltd | 990 Cr. | 44.1 | 56.5/21.2 | 161 | 47.7 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
| Natco Pharma Ltd | 27,185 Cr. | 1,515 | 1,639/724 | 16.6 | 327 | 0.63 % | 30.1 % | 25.9 % | 2.00 |
| Morepen Laboratories Ltd | 4,593 Cr. | 83.8 | 101/31.3 | 39.0 | 16.6 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
| Marksans Pharma Ltd | 12,435 Cr. | 274 | 299/97.4 | 37.4 | 45.6 | 0.22 % | 20.6 % | 16.5 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 202 Cr. | 127 | 145/85.2 | 63.6 | 89.9 | 0.00 % | 1.19 % | 6.15 % | 10.0 |
| Lyka Labs Ltd | 527 Cr. | 147 | 173/97.9 | 573 | 17.9 | 0.00 % | 3.95 % | 6.61 % | 10.0 |
| Lupin Ltd | 99,095 Cr. | 2,172 | 2,312/1,092 | 43.8 | 314 | 0.37 % | 15.7 % | 14.1 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,460 Cr. | 728 | 814/471 | 14.9 | 296 | 0.25 % | 22.5 % | 17.0 % | 10.0 |
| Laurus Labs Ltd | 25,388 Cr. | 470 | 518/349 | 106 | 78.1 | 0.17 % | 7.50 % | 5.43 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 801 Cr. | 772 | 865/309 | 24.9 | 218 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 194 Cr. | 90.6 | 122/60.0 | 55.3 | 0.00 % | 19.0 % | % | 10.0 | |
| Kopran Ltd | 1,562 Cr. | 324 | 370/185 | 26.4 | 102 | 0.93 % | 13.8 % | 11.0 % | 10.0 |
| Kilitch Drugs (India) Ltd | 592 Cr. | 369 | 470/228 | 58.1 | 110 | 0.00 % | 12.8 % | 7.83 % | 10.0 |
| Jubilant Pharmova Ltd | 18,692 Cr. | 1,174 | 1,247/319 | 79.8 | 341 | 0.43 % | 6.74 % | 0.76 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 29,248 Cr. | 1,886 | 2,030/1,244 | 49.8 | 188 | 0.65 % | 24.6 % | 20.0 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,070 Cr. | 405 | 452/270 | 47.0 | 70.9 | 1.24 % | 17.0 % | 13.0 % | 5.00 |
| Ipca Laboratories Ltd | 36,956 Cr. | 1,454 | 1,480/878 | 69.7 | 250 | 0.28 % | 12.8 % | 9.35 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,820 Cr. | 482 | 538/331 | 23.7 | 274 | 1.04 % | 12.3 % | 8.68 % | 10.0 |
| Glenmark Pharmaceuticals Ltd | 46,555 Cr. | 1,650 | 1,774/702 | 278 | 0.15 % | 12.3 % | 50.9 % | 1.00 | |
| Glaxosmithkline Pharmaceuticals Ltd | 45,712 Cr. | 2,698 | 3,088/1,385 | 59.4 | 105 | 1.19 % | 51.3 % | 37.3 % | 10.0 |
| Dr Reddys Laboratories Ltd | 1,08,508 Cr. | 6,503 | 7,107/5,206 | 19.5 | 1,694 | 0.62 % | 26.5 % | 21.4 % | 5.00 |
| Dishman Carbogen Amcis Ltd | 2,867 Cr. | 183 | 283/133 | 359 | 0.00 % | 0.02 % | 2.64 % | 2.00 | |
| Cipla Ltd | 1,32,255 Cr. | 1,638 | 1,683/1,132 | 29.8 | 331 | 0.79 % | 22.8 % | 16.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 14,582 Cr. | 1,918 | 2,159/950 | 30.6 | 276 | 0.26 % | 26.5 % | 24.2 % | 2.00 |
| Brooks Laboratories Ltd | 395 Cr. | 150 | 186/72.5 | 25.0 | 0.00 % | 24.7 % | 28.1 % | 10.0 | |
| Bliss GVS Pharma Ltd | 1,305 Cr. | 124 | 150/77.4 | 12.3 | 92.4 | 0.40 % | 14.4 % | 10.2 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 126 Cr. | 77.7 | 92.0/42.6 | 201 | 11.2 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
| Biocon Ltd | 43,402 Cr. | 362 | 396/218 | 27.8 | 165 | 0.14 % | 5.96 % | 5.25 % | 5.00 |
| Beta Drugs Ltd | 1,648 Cr. | 1,714 | 1,985/892 | 45.2 | 163 | 0.00 % | 36.0 % | 29.6 % | 10.0 |
| Bal Pharma Ltd | 203 Cr. | 127 | 158/81.2 | 26.9 | 43.4 | 0.94 % | 12.1 % | 11.1 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 187 Cr. | 79.1 | 113/73.2 | 297 | 34.2 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
| Astrazeneca Pharma India Ltd | 16,791 Cr. | 6,716 | 7,572/4,050 | 128 | 285 | 0.36 % | 31.1 % | 22.9 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,259 Cr. | 781 | 863/556 | 53.0 | 99.8 | 0.59 % | 21.3 % | 15.5 % | 1.00 |
| Alpa Laboratories Ltd | 241 Cr. | 115 | 128/69.6 | 12.8 | 77.0 | 0.00 % | 13.4 % | 11.0 % | 10.0 |
| Alkem Laboratories Ltd | 73,375 Cr. | 6,137 | 6,440/3,440 | 34.2 | 862 | 0.65 % | 19.7 % | 19.6 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 22,517 Cr. | 1,146 | 1,286/707 | 35.8 | 245 | 0.96 % | 13.1 % | 13.3 % | 2.00 |
| Albert David Ltd | 833 Cr. | 1,460 | 1,754/726 | 11.8 | 671 | 0.79 % | 27.8 % | 21.7 % | 10.0 |
| Ajanta Pharma Ltd | 39,953 Cr. | 3,198 | 3,486/1,650 | 46.8 | 283 | 1.13 % | 31.6 % | 23.2 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 5,808 Cr. | 519 | 571/291 | 39.2 | 118 | 0.98 % | 15.2 % | 11.2 % | 2.00 |
| Aarti Drugs Limited | 4,768 Cr. | 519 | 635/430 | 36.9 | 128 | 0.19 % | 13.7 % | 12.4 % | 10.0 |
| Industry Average | 20,851.73 Cr | 1,267.97 | 63.52 | 187.19 | 0.29% | 16.83% | 16.05% | 6.69 |
